Mayo Clinic heart specialists are collaborating with two Arizona pediatric organizations to offer care to patients with congenital heart disease.
Arizona Pediatric Cardiology Consultants (APCC), an affiliate of Cardiology Specialists Pediatrix, and Phoenix Children's Hospital (PCH) care for many children with congenital heart problems. As they reach adulthood, these patients need continuing care.
Mayo will collaborate with PCH and APCC to provide care to adult patients with congenital heart disease. Patients will have surgery, or medical treatment, on Mayo's Phoenix campus.
On Feb. 1, members of the Endovascular Therapy Program performed the 200th endovascular abdominal aortic aneurysm repair since the program's inception in 2000. The program is a collaboration between the divisions of Vascular Surgery and Vascular and Interventional Radiology for minimally invasive treatment of aortic aneurysms.
Following a thorough review of landmark trials, Mayo Clinic researchers have substantiated the potential dangers of trastuzumab (Herceptin) for certain patients. Their analysis indicates that symptomatic heart failure may occur in up to 4 percent of patients administered the drug.
In studying the treatment results of hundreds of patients, the Mayo team discovered that the risk of cardiotoxicity leading to heart failure was significantly increased when a trastuzumab regimen included additional drugs known as anthracyclines. However, most patients who developed cardiotoxicity while receiving trastuzumab therapy improved once its use was discontinued. Their findings were published in a recent Mayo Clinic Proceedings article.
Blue Cross Blue Shield (BCBS) Association recently selected Mayo Clinic in Arizona as a Blue Distinction Center for Complex and Rare Cancers. BCBS Association awarded this distinction after thoroughly evaluating all aspects of cancer care at Mayo Clinic.
Paul F. Bright, M.D.
Psychiatry and Psychology
Shabana F. Pasha, M.D.
Gastroenterology and Hepatology
Cathleen M. Rivera, M.D.
Women's Health - Internal Medicine
Helen J. Ross, M.D.
Hematology/Oncology
Mayo Clinic is conducting a phase-2 randomized, double-blind, placebo-controlled, multicenter trial to assess the efficacy of two dose levels of DX-88 (ecallantide) versus placebo in reducing blood loss following cardiopulmonary bypass (CPB), as measured by chest tube drainage during the first 12 hours postoperatively or until the chest tube is removed, whichever comes first, in patients undergoing primary coronary artery bypass grafting (CABG), single-valve repair or single-valve replacement.
Contact: Alina Grigore, M.D., Principal Investigator, (480) 342-1800 or Erwin Guyah, R.N., Study Coordinator, (480) 342-3409
Key inclusion criteria include:
Contact: Kellye Wagner, study coordinator, (480) 342-2922
An investigational device study of a brain stimulation system for treating refractory epilepsy. Key inclusion criteria include:
Contact: Tiffany Koch, study coordinator, (480) 342-2189
Mayo Clinic is recruiting patients for a phase-3, multicenter trial (sponsored by NeuroPace, Inc.) of an implantable biomedical device with FDA approval for investigational use. The primary efficacy analysis will be used to establish superiority of the therapy on group to the therapy off group in reducing the frequency of total disabling seizures during the blinded evaluation period of the investigation.
Contact: Richard Zimmerman, M.D., principal investigator, (480) 342-3518 or Beth Gleason, study coordinator, (480) 342-3007.
Key inclusion criteria:
Contact: David Fortuin, M.D., principal investigator or Kellye Wagner, study coordinator, (480) 342-2922
Key inclusion criteria:
Contact: Danette Musil, R.N., study coordinator, (480) 301-6253
The Mayo Clinic Division of Gastroenterology is recruiting participants (40-80 years of age) in a research study to determine whether treatment with selenium can decrease the risk of developing recurrent colon polyps. Eligible participants must have had a colonoscopy where a precancerous polyp was found and removed.
Contact: Narcelle Jean-Louis, clinical research coordinator, (480) 301-4714
CME courses sponsored by Mayo Clinic in Arizona.
Clinical trials at Mayo Clinic in Arizona
Subscribe to Physician Update e-mail newsletter. Information about patient care, education and research activities at Mayo.
See a sample issue.